These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14566683)

  • 21. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
    Jakubicková L; Biesová Z; Pastoreková S; Kettmann R; Pastorek J
    Int J Oncol; 2005 Apr; 26(4):1121-7. PubMed ID: 15754010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis.
    de Martino M; Klatte T; Seligson DB; LaRochelle J; Shuch B; Caliliw R; Li Z; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    J Urol; 2009 Aug; 182(2):728-34. PubMed ID: 19539328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MN/CA9: a potential gene marker for detection of malignant cells in effusions.
    Li G; Passebosc-Faure K; Feng G; Lambert C; Cottier M; Gentil-Perret A; Fournel P; Pérol M; Genin C
    Biomarkers; 2007; 12(2):214-20. PubMed ID: 17536770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of carbonic anhydrase IX (CA9) sensitizes renal cell carcinoma to ionizing radiation.
    Duivenvoorden WC; Hopmans SN; Gallino D; Farrell T; Gerdes C; Glennie D; Lukka H; Pinthus JH
    Oncol Rep; 2015 Oct; 34(4):1968-76. PubMed ID: 26252502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of carbonic anhydrase 9-expressing tumor cells in the lymph nodes of vulvar carcinoma patients by RT-PCR.
    Kowalewska M; Radziszewski J; Kulik J; Barathova M; Nasierowska-Guttmajer A; Bidziński M; Pastorek J; Pastorekova S; Siedlecki JA
    Int J Cancer; 2005 Oct; 116(6):957-62. PubMed ID: 15856466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A potential for tissue restrictive gene therapy in renal cell carcinoma using MN/CA IX promoter.
    Ou YC; Gardner TA; Kao C; Zhau HE; Chung LW
    Anticancer Res; 2005; 25(2A):881-6. PubMed ID: 15868923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
    Tostain J; Li G; Gentil-Perret A; Gigante M
    Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of circulating tumor cells in patients with renal cell carcinoma by reverse transcriptase polymerase chain reaction for G250/MNCA-9: results of a prospective trial.
    Ohlmann CH; Ozgür E; Schrader AJ; Konrad L; Hofmann R; Engelmann U; Heidenreich A
    Urol Oncol; 2006; 24(4):287-93. PubMed ID: 16818180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of the MN/CA9 gene is associated with hypomethylation in human renal cell carcinoma cell lines.
    Cho M; Grabmaier K; Kitahori Y; Hiasa Y; Nakagawa Y; Uemura H; Hirao Y; Ohnishi T; Yoshikawa K; Ooesterwijk E
    Mol Carcinog; 2000 Mar; 27(3):184-9. PubMed ID: 10708480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus.
    Lim HY; Ahn M; Chung HC; Gardner TA; Kao C; Lee SJ; Kim SJ
    Cancer Gene Ther; 2004 Aug; 11(8):532-8. PubMed ID: 15167900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of prostate-specific membrane antigen expressing cells in blood obtained from renal cancer patients: a potential biomarker of vascular invasion.
    de la Taille A; Cao Y; Sawczuk IS; Nozemu T; d'Agati V; McKiernan JM; Bagiella E; Buttyan R; Burchardt M; Olsson CA; Bander N; Katz AE
    Cancer Detect Prev; 2000; 24(6):579-88. PubMed ID: 11198272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CA9 as a biomarker in preoperative biopsy of small solid renal masses for diagnosis of clear cell renal cell carcinoma.
    Li G; Feng G; Zhao A; Péoc'h M; Cottier M; Mottet N
    Biomarkers; 2017 Mar; 22(2):123-126. PubMed ID: 27775441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating large extracellular vesicles carrying CA9 in the diagnosis and prognosis of clear-cell renal cell carcinoma.
    Vergori L; Martinez MC; Bigot P
    Clin Transl Med; 2021 Mar; 11(3):e358. PubMed ID: 33783991
    [No Abstract]   [Full Text] [Related]  

  • 34. CA9 as a molecular marker for differential diagnosis of cystic renal tumors.
    Li G; Bilal I; Gentil-Perret A; Feng G; Zhao A; Peoc'h M; Genin C; Tostain J; Gigante M
    Urol Oncol; 2012; 30(4):463-8. PubMed ID: 20822935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma.
    Cho M; Uemura H; Kim SC; Kawada Y; Yoshida K; Hirao Y; Konishi N; Saga S; Yoshikawa K
    Br J Cancer; 2001 Aug; 85(4):563-7. PubMed ID: 11506497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of circulating cancer cells with von hippel-lindau gene mutation in peripheral blood of patients with renal cell carcinoma.
    Ashida S; Okuda H; Chikazawa M; Tanimura M; Sugita O; Yamamoto Y; Nakamura S; Moriyama M; Shuin T
    Clin Cancer Res; 2000 Oct; 6(10):3817-22. PubMed ID: 11051223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
    Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
    Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of carbonic anhydrase 9 at the invasion front of gastric cancers.
    Chen J; Röcken C; Hoffmann J; Krüger S; Lendeckel U; Rocco A; Pastorekova S; Malfertheiner P; Ebert MP
    Gut; 2005 Jul; 54(7):920-7. PubMed ID: 15951534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells.
    Bleumer I; Tiemessen DM; Oosterwijk-Wakka JC; Völler MC; De Weijer K; Mulders PF; Oosterwijk E
    J Immunother; 2007 Jan; 30(1):116-22. PubMed ID: 17198090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cadherin-6 gene expression in conventional renal cell carcinoma: a useful marker to detect circulating tumor cells.
    Li G; Passebosc-Faure K; Gentil-Perret A; Lambert C; Genin C; Tostain J
    Anticancer Res; 2005; 25(1A):377-81. PubMed ID: 15816561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.